Drug Database
Back to search

Japan· JP-2160006F1026

リザトリプタン安息香酸塩

A medicinal product containing リザトリプタン安息香酸塩, registered in Japan by オルガノン, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedリザトリプタン安息香酸塩ATC—REGISTER NO.JP-2160006F1026PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about リザトリプタン安息香酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)
Active substance
リザトリプタン安息香酸塩
Manufacturer
オルガノン
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

リザトリプタン安息香酸塩 in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All リザトリプタン安息香酸塩 products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Germany · Rizatriptan Al, Rizatriptan Glenmark
  • Denmark · Rizasmelt, Rizatriptan ”stada”
  • Spain · Rizatriptán Flas Kern Pharma, Rizatriptán Max Viatris
  • Finland · Rizastad, Rizatriptan Stada
  • France · Rizatriptan Eg, Rizatriptan Viatris
  • United Kingdom (Northern Ireland) · Rizatriptan Glenmark Pharmaceuticals Europe, Rizatriptan Macleods Pharma Uk
  • Croatia · Emalt
  • Italy · Rizatriptan Mylan Generics, Rizatriptan Sandoz
  • Netherlands · Rizatriptan Sandoz, Rizatriptan Viatris
  • Sweden · Rizasmelt, Rizatriptan Glenmark
  • Slovakia · Rizatriptan Sandoz, Rizatriptan Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9f850c5-3f7d-4898-8a2a-8afc8b833e8b
GET /v1/drugs/a9f850c5-3f7d-4898-8a2a-8afc8b833e8b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１０ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2160006F1026",
  "category": "内用薬",
  "price_yen": 177.6,
  "generic_name": "リザトリプタン安息香酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2160",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about リザトリプタン安息香酸塩.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console